MarketPR
In focus for LLY holders: an ongoing lawsuit against Novo Nordisk (NVO) has drawn Eli Lilly into a formal position on its own marketing conduct.
The company expressed support for its advertising practices in connection with the proceeding. The next confirmable development is a court filing or ruling that moves the case forward.
The company's position Eli Lilly's stated support for its advertising practices is the material disclosure at this stage. The company has placed itself behind its existing marketing approach.
The lawsuit is directed at Novo Nordisk, and Eli Lilly has weighed in on its own advertising conduct in that context.
Keep reading